Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103554082B details a safer scalable route for 3-(4-amino-1-isoindolone-2-yl) piperidine-2,6-diketone manufacturing reducing toxic waste and operational hazards significantly.
Patent CN104876820B enables high-yield catalytic synthesis of aryl formate compounds. Delivers substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced synthesis route for Dabigatran Etexilate Mesylate avoiding high-pressure hydrogenation. Delivers high purity, low moisture, and scalable manufacturing for global supply chains.
Patent CN113929605B reveals a metal-free [2,3]-rearrangement for ortho-sulfonylation. Offers mild conditions, high regioselectivity, and cost-effective API intermediate manufacturing.
Novel low-cost synthesis of 2-O-(3-aminopropyl hydrogen phosphoryl)-ascorbic acid via phosphorylation. High purity, scalable process for skincare actives.
Patent CN101624328A reveals a high-yield, one-step synthesis for (E)-1-chloro-6,6-dimethyl-2-hepten-4-yne. Discover cost-effective manufacturing strategies for this key antifungal intermediate.
Patent CN108084161A details a novel Delafloxacin synthesis route offering high purity and yield. This report analyzes cost reduction in API manufacturing and supply chain reliability for global buyers.
Patent CN117510306A reveals a novel 3-Phenanthrol synthesis route. Achieve higher purity without chromatography. Reliable supply chain for pharmaceutical intermediates.
Patent CN116003326A details a novel Rh-catalyzed one-pot synthesis of trifluoromethyl indazoles. This method offers mild conditions, broad substrate scope, and significant cost reduction in API manufacturing.
Patent CN101314559B details a low-cost kinetic resolution method for aromatic chiral secondary alcohols using Boc-Proline, offering high purity for pharma intermediates.
Novel cycloisomerization method for high-purity deuterated chromone intermediates. Offers improved yield and deuteration rates for pharmaceutical applications.
Novel Wittig reaction route ensures high purity impurity standard for Rosuvastatin Calcium quality control and regulatory compliance supply chain.
Novel nickel-catalyzed oxidation route for Acalabrutinib key intermediate reduces cost and pollution while ensuring high purity for pharma supply chains.
Patent CN108299401B discloses a high-yield synthesis of 3-benzyl coumarin-imidazole salts. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel microwave-assisted method for trans-stilbene intermediates reduces costs and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN108424380A enables efficient copper-catalyzed synthesis. Reduces manufacturing costs and ensures supply continuity for high-purity pharmaceutical intermediates.
Patent CN110551037B details a high-efficiency iridium/chiral diphosphine system for asymmetric hydrogenation, offering superior enantioselectivity for agrochemical intermediates.
Advanced convergent synthesis for Gefitinib intermediates eliminating chromatography. High-purity API manufacturing solutions for global pharmaceutical supply chains.
Patent CN110590823A reveals non-transition metal catalysis for borate derivatives. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN114874153B reveals metal-free oxidative cyclization for naphtho[2,1-d]oxazoles. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.